Abuja – National Agency for Food and Drug Administration and Control (NAFDAC) is collaborating with GS1 to substandard and falsified medicines in the supply chain thus safeguarding the health of Nigerians.
This, according to Director General NAFDAC, Prof. Moji Adeyeye is to ensure that these regulated products are traceable with the aims of eliminating substandard and falsified medicines (SFs) in the supply chain, thus safeguarding the health of the population.
CRUSH 2019 OAU Post UTME, OAU Pre-Degree And OAU JUPEB @ Akahi Tutors, Ile-Ife. Call; 08038644328 or Click Here For Details
She made this known on Wednesday in Abuja to herald the second edition of the African Healthcare Conference scheduled to hold on the 17th to 19th of September 2019 in Lagos.
She hinted that NAFDAC is co-hosting the conference as a continuum in fulfilling the agency’s mandate that includes the control of distribution sale and use (or supply chain) of medicines and medical products.
Her words: “WHO recently estimated 1 in 10 medical products circulating in low and middle-income countries to be either substandard or falsified especially in Africa, that accounts for 42% of the detected cases worldwide.
“Addressing this situation may help prevent widespread loss of life in this continent including an estimated 64,000-158,000 avoidable deaths from malaria alone. Furthermore, falsified medication has an economic impact and results in less trust in the healthcare system”, she added.
The GS1 Healthcare conference will provide a unique opportunity for healthcare stakeholders to discuss how to work together across Africa to achieve better traceability of pharmaceuticals and to improve patient safety
The conference is supported by the World Bank, Global Fund, USAID, and International Federation of Pharmaceutical Manufacturers (IFPMA).
The CEO GS1, Mr. Tunde Odunlami said NAFDAC is doing the phenomenal job but they are here to improve what NAFDAC has been doing.
He added that GS1 has developed standards across the globe and one of the standards is focused on patients’ safety.
The post NAFDAC, GS1 Partners To Eliminate Substandard, Falsified Medicines In Nigeria appeared first on Independent Newspapers Nigeria.
Categories: Latest News